JP7512251B2 - 病的炎症の新しい医療 - Google Patents
病的炎症の新しい医療 Download PDFInfo
- Publication number
- JP7512251B2 JP7512251B2 JP2021506258A JP2021506258A JP7512251B2 JP 7512251 B2 JP7512251 B2 JP 7512251B2 JP 2021506258 A JP2021506258 A JP 2021506258A JP 2021506258 A JP2021506258 A JP 2021506258A JP 7512251 B2 JP7512251 B2 JP 7512251B2
- Authority
- JP
- Japan
- Prior art keywords
- ethyl
- hydrogen
- alkyl
- asa
- diethylamino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18189194.6 | 2018-08-15 | ||
| EP18189194 | 2018-08-15 | ||
| PCT/EP2019/071903 WO2020035554A1 (en) | 2018-08-15 | 2019-08-15 | A new medical treatment for pathologic inflammation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022501315A JP2022501315A (ja) | 2022-01-06 |
| JP2022501315A5 JP2022501315A5 (cg-RX-API-DMAC7.html) | 2022-08-17 |
| JP7512251B2 true JP7512251B2 (ja) | 2024-07-08 |
Family
ID=63294023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021506258A Active JP7512251B2 (ja) | 2018-08-15 | 2019-08-15 | 病的炎症の新しい医療 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11896564B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3836912B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7512251B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102954666B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN112770736B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019322564A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021001984A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3108361A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL280548A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021001349A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020035554A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102954667B1 (ko) * | 2018-08-15 | 2026-04-17 | 파마실 아베 | 치환된 벤즈아미드 및 치료법에서 이의 용도 |
| US11717500B2 (en) * | 2020-02-03 | 2023-08-08 | Pharmacyl Ab | Treatment of spondyloarthritis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002517439A (ja) | 1998-06-08 | 2002-06-18 | オキシジェン,インコーポレイティド | N−アセチル3−クロロプロカインアミド、それらの酸付加塩、および使用方法 |
| WO2018037103A1 (en) | 2016-08-26 | 2018-03-01 | Idogen Ab | Procainamide for treating immune disorders and for modulating ido expression |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL281394A (cg-RX-API-DMAC7.html) | 1961-07-25 | |||
| US6028111A (en) | 1996-03-08 | 2000-02-22 | Oxigene, Inc. | Compositions and use of benzamides and nicotinamides as anti-inflammatory agents |
| US6518312B2 (en) | 2000-07-05 | 2003-02-11 | Active Biotech Ab | Immune enhancement |
| US7157444B2 (en) | 2002-12-21 | 2007-01-02 | Deanna Jean Nelson | Aminosalicylate derivatives for treatment of inflammatory bowel disease |
| WO2005025498A2 (en) | 2003-09-08 | 2005-03-24 | Corus Pharma | Substituted acetanilides and benzamides for the treatment of asthma and pulmonary inflammation |
| SE0400235D0 (sv) | 2004-02-06 | 2004-02-06 | Active Biotech Ab | New composition containing quinoline compounds |
| DE102004011720B4 (de) | 2004-03-10 | 2008-04-03 | Bayer Schering Pharma Aktiengesellschaft | Radiohalogenierte Benzamidderivate und deren Verwendung in der Tumordiagnostik und Tumortherapie |
| ATE554770T1 (de) * | 2006-04-13 | 2012-05-15 | Taiho Pharmaceutical Co Ltd | Therapeutisches mittel gegen entzündliche darmerkrankungen |
| KR101216756B1 (ko) * | 2007-12-18 | 2012-12-28 | 메이지 세이카 파루마 가부시키가이샤 | 염증성 장질환의 예방 또는 치료제 |
-
2019
- 2019-08-15 BR BR112021001984-7A patent/BR112021001984A2/pt not_active IP Right Cessation
- 2019-08-15 CN CN201980051160.XA patent/CN112770736B/zh active Active
- 2019-08-15 KR KR1020217006280A patent/KR102954666B1/ko active Active
- 2019-08-15 JP JP2021506258A patent/JP7512251B2/ja active Active
- 2019-08-15 AU AU2019322564A patent/AU2019322564A1/en not_active Abandoned
- 2019-08-15 EP EP19750131.5A patent/EP3836912B1/en active Active
- 2019-08-15 MX MX2021001349A patent/MX2021001349A/es unknown
- 2019-08-15 US US17/264,924 patent/US11896564B2/en active Active
- 2019-08-15 WO PCT/EP2019/071903 patent/WO2020035554A1/en not_active Ceased
- 2019-08-15 CA CA3108361A patent/CA3108361A1/en active Pending
-
2021
- 2021-02-01 IL IL280548A patent/IL280548A/en unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002517439A (ja) | 1998-06-08 | 2002-06-18 | オキシジェン,インコーポレイティド | N−アセチル3−クロロプロカインアミド、それらの酸付加塩、および使用方法 |
| WO2018037103A1 (en) | 2016-08-26 | 2018-03-01 | Idogen Ab | Procainamide for treating immune disorders and for modulating ido expression |
Non-Patent Citations (4)
| Title |
|---|
| British Journal of Cancer,1999年,VOl.81, No.6,pp.981-988 |
| J Clin Invest.,1998年,Vol.101, No.5,pp.1163-1174 |
| Molecular Immunology,2001年,Vol.38,pp.267-277 |
| 日本臨床,1999年,Vol.57, No.11,pp.2476-2480 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20220087959A1 (en) | 2022-03-24 |
| EP3836912A1 (en) | 2021-06-23 |
| CA3108361A1 (en) | 2020-02-20 |
| EP3836912C0 (en) | 2024-05-01 |
| CN112770736B (zh) | 2025-01-21 |
| US11896564B2 (en) | 2024-02-13 |
| KR102954666B1 (ko) | 2026-04-20 |
| WO2020035554A1 (en) | 2020-02-20 |
| JP2022501315A (ja) | 2022-01-06 |
| EP3836912B1 (en) | 2024-05-01 |
| CN112770736A (zh) | 2021-05-07 |
| MX2021001349A (es) | 2021-04-13 |
| AU2019322564A1 (en) | 2021-03-25 |
| IL280548A (en) | 2021-03-25 |
| BR112021001984A2 (pt) | 2021-05-11 |
| KR20210045414A (ko) | 2021-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7702654B2 (ja) | トリプタミンプロドラッグ | |
| Ali et al. | Belumosudil with ROCK-2 inhibition: chemical and therapeutic development to FDA approval for the treatment of chronic graft-versus-host disease | |
| JP2020536977A (ja) | 新規な誘導体を有効成分として含むtnf−関連疾患の予防または治療用の組成物およびこれを用いたtnf活性阻害方法 | |
| WO2020035040A1 (zh) | 3-芳氧基-3-五元杂芳基-丙胺类化合物及其用途 | |
| ES2802977T3 (es) | Compuesto para la modulación inmunológica, uso del mismo y composición farmacéutica que lo comprende | |
| WO2016159577A2 (ko) | 1,2 나프토퀴논 유도체 및 이의 제조방법 | |
| JP7181565B2 (ja) | Yap-tead結合を阻害する化合物、およびそれを有効成分として含有する癌の予防または治療用医薬組成物 | |
| TW201940486A (zh) | 抑制瞬時受體電位a1離子通道 | |
| CA3140231A1 (en) | 3-aryloxyl-3-five-membered heteroaryl-propylamine compound, and crystal form and use thereof | |
| CN112770736B (zh) | 病理性炎症的新医学治疗 | |
| WO2020228789A1 (zh) | 3-芳氧基-3-五元杂芳基-丙胺类化合物及其晶型和用途 | |
| US20250064761A1 (en) | Substituted benzamides and their use in therapy | |
| US11717500B2 (en) | Treatment of spondyloarthritis | |
| JPWO2014129513A1 (ja) | 潰瘍性大腸炎の予防または治療剤と新規フラーレン誘導体 | |
| WO2013064714A1 (es) | Fármacos inhibidores de p38 y aplicaciones | |
| CN112823008A (zh) | 包含组蛋白脱乙酰酶抑制剂和氨甲蝶呤的药物组合物 | |
| KR102532517B1 (ko) | 신규한 설폰아미드 화합물 및 이를 유효 성분으로 함유하는 암의 예방 또는 치료용 약제학적 조성물 | |
| CN104478798A (zh) | N-氨基烷基磺酰基-3-吡啶甲酰胺衍生物及其在制备治疗心脑血管病药物中的应用 | |
| JP2017002044A (ja) | ソリフェナシンまたはその薬学的に許容される塩とラクトースとを含む安定した無定形粉末およびその調製方法 | |
| HK40045171A (en) | Pharmaceutical composition comprising histone deacetylase inhibitor and methotrexate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220808 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220808 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230804 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20231030 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240205 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240529 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240626 |